Shares of Heat Biologics, Inc. (NASDAQ:HTBX) Explode Following Award Granted to its Subsidiary, Pelican Therapeutics

Shares of Heat Biologics, Inc. (NASDAQ:HTBX) Explode Following Award Granted to its Subsidiary, Pelican Therapeutics

Leader in the development of cancer therapies, Heat Biologics, Inc. (NASDAQ:HTBX), announced that its subsidiary, Pelican Therapeutics, has received a grant reward of $15.2 million. DURHAM, NC / ACCESSWIRE / June 28, 2017 / Heat Biologics, Inc. (“Heat”) (HTBX), a leader in the development of novel therapies designed to activate a patient’s immune system against cancer, reported that its Pelican Therapeutics subsidiary is on track to meet product development milestones […]

Read More ˃